Open AccessAdaptive ERK1/2 signalling as a response to HNSCC therapy
Author(s) -
Annette Affolter,
Rong Chen,
M Müller,
Xiang Fei,
Ashley W. Jensen,
Wilko Weichert,
Gerald Major,
PK Plinkert,
Nicole Rotter,
Julia Heß
Publication year - 2020
Publication title -
laryngo-rhino-otologie
Language(s) - English
Resource type - Conference proceedings
eISSN - 1438-8685
pISSN - 0935-8943
DOI - 10.1055/s-0040-1710929
Subject(s) - cetuximab , head and neck squamous cell carcinoma , monoclonal antibody , mapk/erk pathway , epidermal growth factor receptor , cancer research , in silico , egfr inhibitors , medicine , kinase , oncology , radiation therapy , antibody , head and neck cancer , biology , cancer , immunology , microbiology and biotechnology , gene , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom